Search Results

There are 18568 results for: content related to: Design for validation of acute myocardial infarction cases in Mini-Sentinel

  1. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Version of Record online : 8 JUN 2012, DOI: 10.1002/pds.3296

  2. You have free access to this content
    Design considerations, architecture, and use of the Mini-Sentinel distributed data system

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 23–31, Lesley H. Curtis, Mark G. Weiner, Denise M. Boudreau, William O. Cooper, Gregory W. Daniel, Vinit P. Nair, Marsha A. Raebel, Nicolas U. Beaulieu, Robert Rosofsky, Tiffany S. Woodworth and Jeffrey S. Brown

    Version of Record online : 19 JAN 2012, DOI: 10.1002/pds.2336

  3. You have free access to this content
    A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 265–273, Jasvinder A Singh, Joseph A Kundukulam and Mohit Bhandari

    Version of Record online : 19 JAN 2012, DOI: 10.1002/pds.2309

  4. Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 718–728, Kueiyu Joshua Lin, Luis A. García Rodríguez and Sonia Hernández-Díaz

    Version of Record online : 27 MAY 2011, DOI: 10.1002/pds.2153

  5. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 667–678, Shahrul Mt-Isa, Christine E. Hallgreen, Nan Wang, Torbjörn Callréus, Georgy Genov, Ian Hirsch, Stephen F. Hobbiger, Kimberley S. Hockley, Davide Luciani, Lawrence D. Phillips, George Quartey, Sinan B. Sarac, Isabelle Stoeckert, Ioanna Tzoulaki, Alain Micaleff, Deborah Ashby and On behalf of the IMI-PROTECT benefit–risk participants

    Version of Record online : 13 MAY 2014, DOI: 10.1002/pds.3636

  6. Literature review of visual representation of the results of benefit–risk assessments of medicinal products

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 3, March 2016, Pages: 238–250, Christine E. Hallgreen, Shahrul Mt-Isa, Alfons Lieftucht, Lawrence D. Phillips, Diana Hughes, Susan Talbot, Alex Asiimwe, Gerald Downey, Georgy Genov, Richard Hermann, Rebecca Noel, Ruth Peters, Alain Micaleff, Ioanna Tzoulaki, Deborah Ashby and On behalf of PROTECT Benefit–Risk group

    Version of Record online : 2 NOV 2015, DOI: 10.1002/pds.3880

  7. Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 7, July 2016, Pages: 798–814, Marsha A. Raebel, Susan Shetterly, Christine Y. Lu, James Flory, Joshua J. Gagne, Frank E. Harrell, Kevin Haynes, Lisa J. Herrinton, Elisabetta Patorno, Jennifer Popovic, Mano Selvan, Azadeh Shoaibi, Xingmei Wang and Jason Roy

    Version of Record online : 4 MAY 2016, DOI: 10.1002/pds.4015

  8. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 2, February 2015, Pages: 176–186, Florian Meier, Renke Maas, Anja Sonst, Andrius Patapovas, Fabian Müller, Bettina Plank-Kiegele, Barbara Pfistermeister, Oliver Schöffski, Thomas Bürkle and Harald Dormann

    Version of Record online : 17 JUN 2014, DOI: 10.1002/pds.3663

  9. You have free access to this content
    A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 100–128, Susan E. Andrade, Leslie R. Harrold, Jennifer Tjia, Sarah L. Cutrona, Jane S. Saczynski, Katherine S. Dodd, Robert J. Goldberg and Jerry H. Gurwitz

    Version of Record online : 19 JAN 2012, DOI: 10.1002/pds.2312

  10. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Version of Record online : 17 APR 2013, DOI: 10.1002/pds.3432

  11. You have free access to this content
    Design considerations in an active medical product safety monitoring system

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 32–40, Joshua J. Gagne, Bruce Fireman, Patrick B. Ryan, Malcolm Maclure, Tobias Gerhard, Sengwee Toh, Jeremy A. Rassen, Jennifer C. Nelson and Sebastian Schneeweiss

    Version of Record online : 19 JAN 2012, DOI: 10.1002/pds.2316

  12. Variable selection on large case-crossover data: application to a registry-based study of prescription drugs and road traffic crashes

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 2, February 2014, Pages: 140–151, Marta Avalos, Ludivine Orriols, Hélène Pouyes, Yves Grandvalet, Frantz Thiessard, Emmanuel Lagarde and on behalf of the CESIR research group

    Version of Record online : 18 OCT 2013, DOI: 10.1002/pds.3539

  13. You have free access to this content
    The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 12–17, Susan Forrow, Daniel M. Campion, Lisa J. Herrinton, Vinit P. Nair, Melissa A. Robb, Marcus Wilson and Richard Platt

    Version of Record online : 19 JAN 2012, DOI: 10.1002/pds.2242

  14. Disease risk score as a confounder summary method: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 2, February 2013, Pages: 122–129, Mina Tadrous, Joshua J. Gagne, Til Stürmer and Suzanne M. Cadarette

    Version of Record online : 21 NOV 2012, DOI: 10.1002/pds.3377

  15. Safety profile of oseltamivir during the 2009 influenza pandemic

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 532–543, Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith and Viswanathan Niranjan

    Version of Record online : 29 MAR 2011, DOI: 10.1002/pds.2136

  16. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Version of Record online : 25 NOV 2015, DOI: 10.1002/pds.3912

  17. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 980–990, Anaïs Lacasse, Mark A. Ware, Marc Dorais, Hélène Lanctôt and Manon Choinière

    Version of Record online : 24 JUN 2015, DOI: 10.1002/pds.3820

  18. Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 8, August 2016, Pages: 871–879, Javier Cid Ruzafa, Evie Merinopoulou, Rebecca F. Baggaley, Pamela Leighton, Winifred Werther, Diana Felici and Andrew Cox

    Version of Record online : 19 JAN 2016, DOI: 10.1002/pds.3927

  19. Fifty years of pharmacovigilance – Medicines safety and public health

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 6, June 2016, Pages: 725–732, Joan-Ramon Laporte

    Version of Record online : 22 JAN 2016, DOI: 10.1002/pds.3967

  20. Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 10, October 2013, Pages: 1027–1035, Farshad Kajbaf, Paul Arnouts, Marc de Broe and Jean-Daniel Lalau

    Version of Record online : 19 AUG 2013, DOI: 10.1002/pds.3501